Nextage Therapeutics Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NXTG.TA research report →
Price Chart
About the company
Nextage Therapeutics Ltd, an Israeli company operating from Ness Ziona, focuses on the creation of cannabinoid-derived products.
- CEO
- Orna Dreazen
- IPO
- 2002
- Employees
- 31
- HQ
- Ness Ziona, IL
Get TickerSpark's AI analysis on NXTG.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $31.61M
- P/E
- -2.79
- PEG
- -0.26
- P/S
- 8.79
- P/B
- 1.15
- EV/EBITDA
- -7.36
- Div Yield
- 0.00%
- Gross Margin
- -18.45%
- Op Margin
- -226.46%
- Net Margin
- -168.48%
- ROE
- -139.28%
- ROIC
- -25.82%
Latest fiscal year · YoY change
- Revenue
- $3.60M+771.2%
- Gross Profit
- $-664,000-973.7%
- Op Income
- $-8,148,000
- Net Income
- $-6,062,000-84.6%
- EPS
- $-0.14-27.3%
- OCF Growth
- -741.8%
- FCF Growth
- -742.1%
- 52W High
- $100.00
- 52W Low
- $0.06
- 50D MA
- $42.04
- 200D MA
- $14.81
- Beta
- 0.17
- RSI (14)
- 47
- Avg Volume
- 54.48K
No earnings-call transcripts are available for NXTG.TA yet.
- Free Float
- 6.9%
- Shares Outstanding
- 81.06M
- Float Shares
- 5.63M
Our NXTG.TA coverage
Recent articles, reports, and earnings notes.
No research on NXTG.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NXTG.TA report →